NERV vs DAAQ
Comparison between Minerva Neurosciences Inc (NERV, Company) and Digital Asset Acquisition Corp - Class A (DAAQ, Company).
NERV is from the Healthcare sector, while DAAQ is from the Financial Services sector.
NERV vs DAAQ - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NERV vs DAAQ - Historical Returns
Returns include dividend reinvestment.
NERV vs DAAQ - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | NERV | DAAQ |
|---|---|---|
| 2026 | +1.28% | -13.64% |
| 2025 | +74.78% | -2.31% |
| 2024 | -63.88% | N/A |
| 2023 | +307.28% | N/A |
| 2022 | -78.39% | N/A |
| 2021 | -66.34% | N/A |
| 2020 | -69.37% | N/A |
| 2019 | +2.75% | N/A |
| 2018 | +8.71% | N/A |
| 2017 | -48.51% | N/A |
| 2016 | +99.83% | N/A |
| 2015 | -0.65% | N/A |
| 2014 | -0.50% | N/A |
NERV vs DAAQ Drawdown Comparison
The maximum drawdown for NERV was -98.86%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The maximum drawdown for DAAQ was -37.14%, occurring on Jul 29, 2026. This drawdown has not yet recovered.
The current NERV drawdown is -96.62%. The current DAAQ drawdown is -19.71%.
| Rank | NERV | DAAQ |
|---|---|---|
| #1 | -98.86% May 26, 2020 - Apr 9, 2025 | -37.14% Jun 24, 2025 - Jul 29, 2026 |
| #2 | -71.63% Sep 20, 2016 - May 21, 2020 | -0.56% Jun 13, 2025 - Jun 18, 2025 |
| #3 | -53.73% Sep 10, 2014 - May 26, 2016 | -0.19% Jun 11, 2025 - Jun 13, 2025 |
| #4 | -33.29% Jun 2, 2016 - Sep 20, 2016 | -0.10% Jun 6, 2025 - Jun 11, 2025 |
| #5 | -17.13% Jul 28, 2014 - Sep 9, 2014 | N/A |
| #6 | -13.97% Jul 14, 2014 - Jul 28, 2014 | N/A |
| #7 | -4.07% May 26, 2016 - May 31, 2016 | N/A |
| #8 | -3.75% Jul 3, 2014 - Jul 10, 2014 | N/A |
| #9 | -1.99% May 21, 2020 - May 26, 2020 | N/A |
| #10 | -1.05% Jul 10, 2014 - Jul 14, 2014 | N/A |
| #11 | -0.83% Jul 1, 2014 - Jul 3, 2014 | N/A |
Correlation
Correlation between NERV and DAAQ is 0.01 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks